CJJD 📈 China Jo-Jo Drugstores - Overview
Exchange: NASDAQ • Country: China • Currency: USD • Type: Common Stock • ISIN: KYG2124G1120
CJJD: Prescription Drugs, Vitamins, Supplements, Chinese Medicine, Medical Devices
China Jo-Jo Drugstores, Inc. operates as a retailer and wholesale distributor of pharmaceutical and other healthcare products in the People's Republic of China. The company operates through three segments: Retail Drugstores, Online Pharmacy, and Drug Wholesale. Its stores provide various pharmaceutical products, including prescription and over-the-counter drugs, nutritional supplements, traditional Chinese medicines (TCM), personal and family care products, and medical devices, as well as convenience products, such as consumable, seasonal, and promotional items. The company offers consultation, examination, and treatment of common ailments by licensed doctors in western medicine and TCM at scheduled hours. In addition, it provides treatment for minor ailments, such as sprains, minor lacerations, and dizziness; acupuncture, therapeutic massage, and cupping services; and minor outpatient surgical treatments, including suturing. Further, it offers OTC drugs and nutritional supplements through its website www.dada360.com, as well as sells products through third-party platforms. Additionally, the company distributes third-party pharmaceutical products to trading companies, as well as cultivates and wholesales herbs used for TCM. It operates pharmacies under the Jiuzhou Grand Pharmacy name. China Jo-Jo Drugstores, Inc. is headquartered in Hangzhou, the People's Republic of China. Web URL: https://www.jiuzhou360.com
Additional Sources for CJJD Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CJJD Stock Overview
Market Cap in USD | 13m |
Sector | Healthcare |
Industry | Pharmaceutical Retailers |
GiC Sub-Industry | Drug Retail |
IPO / Inception | 2008-05-16 |
CJJD Stock Ratings
Growth 5y | -97.4% |
Fundamental | 20.5% |
Dividend | - |
Rel. Strength Industry | -456 |
Analysts | - |
Fair Price Momentum | 0.58 USD |
Fair Price DCF | - |
CJJD Dividends
No Dividends PaidCJJD Growth Ratios
Growth Correlation 3m | -4.3% |
Growth Correlation 12m | -87.8% |
Growth Correlation 5y | -97.4% |
CAGR 5y | -67.07% |
CAGR/Mean DD 5y | -0.83 |
Sharpe Ratio 12m | -0.50 |
Alpha | -71.54 |
Beta | 0.51 |
Volatility | 75.08% |
Current Volume | 5.9k |
Average Volume 20d | 5.8k |
What is the price of CJJD stocks?
As of December 22, 2024, the stock is trading at USD 1.66 with a total of 5,906 shares traded.
Over the past week, the price has changed by -10.27%, over one month by -10.27%, over three months by +3.75% and over the past year by -57.73%.
As of December 22, 2024, the stock is trading at USD 1.66 with a total of 5,906 shares traded.
Over the past week, the price has changed by -10.27%, over one month by -10.27%, over three months by +3.75% and over the past year by -57.73%.
Is China Jo-Jo Drugstores a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, China Jo-Jo Drugstores is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 20.53 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CJJD as of December 2024 is 0.58. This means that CJJD is currently overvalued and has a potential downside of -65.06%.
Neither. Based on ValueRay Fundamental Analyses, China Jo-Jo Drugstores is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 20.53 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CJJD as of December 2024 is 0.58. This means that CJJD is currently overvalued and has a potential downside of -65.06%.
Is CJJD a buy, sell or hold?
China Jo-Jo Drugstores has no consensus analysts rating.
China Jo-Jo Drugstores has no consensus analysts rating.
What are the forecast for CJJD stock price target?
According to ValueRays Forecast Model, CJJD China Jo-Jo Drugstores will be worth about 0.6 in December 2025. The stock is currently trading at 1.66. This means that the stock has a potential downside of -62.05%.
According to ValueRays Forecast Model, CJJD China Jo-Jo Drugstores will be worth about 0.6 in December 2025. The stock is currently trading at 1.66. This means that the stock has a potential downside of -62.05%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 7 | 321.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 0.6 | -62% |